Details of the Drug Reposition
General Information of This Drug (ID: DMVJMF1)
| Drug Name | ||||||
|---|---|---|---|---|---|---|
| Synonyms | Klerval; RPR-109039; N-Ethyl-N-[4-(4-piperidyl)butyryl]-glycyl-L-aspartyl-L-(3-cyclohexyl)alaninamide | |||||
| Structure |
![]() |
|||||
| 3D MOL is unavailable | 2D MOL | |||||
Information on Drug Reposition of This Drug
| Molecular Interaction Atlas (MIA) | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1 Phase 1 Indication(s)
|
|
|||||||||||||||||||||||||
|
1 Discontinued in Phase 2 Indication(s)
|
|
|||||||||||||||||||||||||
References

